-
'Sartorial diplomacy' on show in expo of late UK queen's fashion
-
Former Japan and AC Milan star Honda laces up boots again at 39
-
Stocks rally on optimism over Iran war ceasefire, oil extends gains
-
Lego-style memes troll Trump after fragile US-Iran truce
-
Chinese slimmers trade lost fat for beef
-
Jackson biopic shows franchise thriving despite abuse claims
-
New Jersey city spurns data center as defiance spreads
-
US box office looking good as cinema owners gather: industry chief
-
Firm Masters greens make life hard on golf's finest
-
Defending champ McIlroy shares Masters lead after back-nine birdie run
-
After oil, Venezuela opens up mining to private investors
-
Tigers' Meadows in hospital after colliding with teammate
-
US to host Israel-Lebanon talks as strikes threaten Iran ceasefire
-
'Scrappy' McIlroy leans on experience for share of Masters lead
-
Ukraine and Russia will cease fire for Orthodox Easter
-
Mateta inspires Palace win over Fiorentina in Conference League
-
Pioneering US hip-hop artist Afrika Bambaataa dies at 68
-
Russia bans Nobel-winning rights group, raids independent newspaper, in one day
-
Pentagon denies giving Vatican envoy 'bitter lecture'
-
Watkins propels Villa towards Europa League semis, Forest hold Porto
-
Aston Villa on verge of Europa League semis after beating Bologna
-
Venezuela police clash with protesters demanding salary rises
-
CAF president rejects corruption claims by Senegal
-
Israel and Lebanon set for ceasefire talks next week, says US official
-
US stocks extend gains, shrugging off ceasefire worries
-
IMF chief urges nations to 'do no harm' in fiscal response to Iran war
-
Sixers' Embiid to have surgery for appendicitis - team
-
Russian police raid independent Novaya Gazeta outlet, reporter detained
-
Former heavyweight king Fury adamant 'I've still got it' as Makhmudov awaits
-
Shipping toll for Hormuz passage sharply divides nations
-
McIlroy's back-nine birdie run grabs share of Masters lead
-
Melania Trump blasts 'lies' linking her to Epstein
-
'Anxious' Tatum back at Madison Square Garden with NBA East second seed on line
-
Strait of Hormuz traffic remains becalmed despite ceasefire
-
Melania Trump denies any links to Epstein abuse
-
American Airlines targets April 30 return to Venezuela
-
Venezuela police tear-gas protesters demanding salary rises
-
Robertson to leave Liverpool at end of season
-
Choudhary smashes Lucknow to dramatic IPL win over Kolkata
-
Sean 'Diddy' Combs asks US appeals court to overturn sentence
-
Verstappen Red Bull future in doubt as engineer to join McLaren
-
France's Macron in Rome for first meeting with Pope Leo
-
Angola name former Senegal boss Cisse as new coach
-
Sinner and Alcaraz wobble but advance to Monte Carlo quarter-finals
-
Reed soars to early Masters lead on wings of eagles
-
US Democrats fail in bid to curb Trump's Iran war powers
-
Veteran prop Slimani to return to France with Toulon
-
Iranians pay tribute to slain supreme leader weeks after killing
-
Russian police raid independent Novaya Gazeta media outlet
-
Barton Snow completes Cheltenham-Aintree double in Foxhunters Chase
CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics
TAMPA, FL / ACCESS Newswire / December 16, 2025 / (OTCQB:CTTH) CTT Pharmaceutical Holdings, Inc. is pleased to announce that a peer-reviewed scientific paper has been published in the journal of Drug Delivery and Therapeutics, authored by our scientist Dr. Katharine Cole and Dr. Pankaj Modi, the founder of CTT Pharma. The article provides the first comprehensive scientific review describing how micellar nanotechnology, when combined with an oral dissolvable strip delivery system, can significantly improve the delivery and bioavailability of active therapeutic compounds. "This review article is an important step forward in bringing wider scientific attention to this innovative and transformative technology," said Dr. Cole.
This publication is available on the Company's website www.cttpharmaceuticals.com in the 'Scientific Publications' section. This section includes peer-reviewed articles authored by CTT scientists that contribute to the broader scientific literature in areas relevant to the company's scientific focus. These publications are provided solely for transparency and informational purposes. Additional publications will be added as they become available.
CTT Pharma
813-606-0060
SOURCE: CTT Pharmaceutical Holdings, Inc.
View the original press release on ACCESS Newswire
A.Anderson--AT